Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Here's What Key Metrics Tell Us About Sweetgreen (SG) Q3 Earnings
Here's What Key Metrics Tell Us About Sweetgreen (SG) Q3 Earnings

Sweetgreen, Inc. (SG) reported $172.39 million in revenue for the quarter ended September 2025, representing a year-over-year decline of 0.6%. EPS of -$0.27 for the same period compares to -$0.18 a

Take-Two Interactive (TTWO) Q2 Earnings and Revenues Beat Estimates
Take-Two Interactive (TTWO) Q2 Earnings and Revenues Beat Estimates

Take-Two Interactive (TTWO) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.66 per share a year ago

10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates

10x Genomics (TXG) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.3 per share a year ago. These figures are

National Health Investors (NHI) Tops Q3 FFO and Revenue Estimates
National Health Investors (NHI) Tops Q3 FFO and Revenue Estimates

National Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.32 per share, beating the Zacks Consensus Estimate of $1.24 per share. This compares to FFO of $1.03 per

Nektar Therapeutics (NKTR) Reports Q3 Loss, Beats Revenue Estimates
Nektar Therapeutics (NKTR) Reports Q3 Loss, Beats Revenue Estimates

Nektar Therapeutics (NKTR) came out with a quarterly loss of $1.85 per share versus the Zacks Consensus Estimate of a loss of $2.85. This compares to a loss of $2.7 per share a year ago. These

Universal Display Corp. (OLED) Lags Q3 Earnings and Revenue Estimates
Universal Display Corp. (OLED) Lags Q3 Earnings and Revenue Estimates

Universal Display Corp. (OLED) came out with quarterly earnings of $0.92 per share, missing the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.4 per share a year ago

JFrog Ltd. (FROG) Surpasses Q3 Earnings and Revenue Estimates
JFrog Ltd. (FROG) Surpasses Q3 Earnings and Revenue Estimates

JFrog Ltd. (FROG) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.15 per share a year ago. These figures

Astrana Health, Inc. (ASTH) Misses Q3 Earnings Estimates
Astrana Health, Inc. (ASTH) Misses Q3 Earnings Estimates

Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.33 per share a year ago

Amphastar Pharmaceuticals (AMPH) Q3 Earnings and Revenues Top Estimates
Amphastar Pharmaceuticals (AMPH) Q3 Earnings and Revenues Top Estimates

Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.93 per share, beating the Zacks Consensus Estimate of $0.77 per share. This compares to earnings of $0.96 per share a year

Affirm Holdings (AFRM) Surpasses Q1 Earnings and Revenue Estimates
Affirm Holdings (AFRM) Surpasses Q1 Earnings and Revenue Estimates

Affirm Holdings (AFRM) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to a loss of $0.31 per share a year ago. These

Nerdy Inc. (NRDY) Reports Q3 Loss, Lags Revenue Estimates
Nerdy Inc. (NRDY) Reports Q3 Loss, Lags Revenue Estimates

Nerdy Inc. (NRDY) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.14 per share a year ago. These figures are

Natera (NTRA) Reports Q3 Loss, Beats Revenue Estimates
Natera (NTRA) Reports Q3 Loss, Beats Revenue Estimates

Natera (NTRA) came out with a quarterly loss of $0.64 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.26 per share a year ago. These figures are

On Holding (ONON) Suffers a Larger Drop Than the General Market: Key Insights
On Holding (ONON) Suffers a Larger Drop Than the General Market: Key Insights

On Holding (ONON) ended the recent trading session at $35.51, demonstrating a -1.58% change from the preceding day's closing price. This change lagged the S&P 500's daily loss of 1.12%. Meanwhile

Genpact (G) Q3 Earnings and Revenues Top Estimates
Genpact (G) Q3 Earnings and Revenues Top Estimates

Genpact (G) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.9 per share. This compares to earnings of $0.85 per share a year ago. These figures are

3 Small AI Stocks Ready to Explode (All Under $20): https://www.marketbeat.com/logos/articles/med_20251106164102_3-small-ai-stocks-ready-to-explode-all-under-20.jpg
3 Small AI Stocks Ready to Explode (All Under $20)

If you’ve ever wished you’d caught the internet boom early—or owned shares of a company like NVIDIA (NASDAQ: NVDA) before it became a $5 trillion tech behemoth—this one’s for you.

Artificial

Mettler-Toledo (MTD) Beats Q3 Earnings and Revenue Estimates
Mettler-Toledo (MTD) Beats Q3 Earnings and Revenue Estimates

Mettler-Toledo (MTD) came out with quarterly earnings of $11.15 per share, beating the Zacks Consensus Estimate of $10.62 per share. This compares to earnings of $10.21 per share a year ago. These

Prothena (PRTA) Reports Q3 Loss, Lags Revenue Estimates
Prothena (PRTA) Reports Q3 Loss, Lags Revenue Estimates

Prothena (PRTA) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.6. This compares to a loss of $1.1 per share a year ago. These figures are

Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates
Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates

Protagonist Therapeutics (PTGX) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to a loss of $0.54 per share a year ago. These

Drilling Tools International Corp. (DTI) Tops Q3 Earnings and Revenue Estimates
Drilling Tools International Corp. (DTI) Tops Q3 Earnings and Revenue Estimates

Drilling Tools International Corp. (DTI) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to earnings of $0.14

IREN Limited (IREN) Reports Q1 Loss, Beats Revenue Estimates
IREN Limited (IREN) Reports Q1 Loss, Beats Revenue Estimates

IREN Limited (IREN) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of $0.14. This compares to a loss of $0.22 per share a year ago. These figures are adjusted

Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note

Veeva Systems (VEEV) ended the recent trading session at $291.21, demonstrating a -1.37% change from the preceding day's closing price. This change lagged the S&P 500's 1.12% loss on the day

Fidelity National Financial (FNF) Q3 Earnings and Revenues Top Estimates
Fidelity National Financial (FNF) Q3 Earnings and Revenues Top Estimates

Fidelity National Financial (FNF) came out with quarterly earnings of $1.63 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.3 per share a year

HireQuest, Inc. (HQI) Surpasses Q3 Earnings and Revenue Estimates
HireQuest, Inc. (HQI) Surpasses Q3 Earnings and Revenue Estimates

HireQuest, Inc. (HQI) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.2 per share a year ago. These

AerSale Corporation (ASLE) Misses Q3 Earnings and Revenue Estimates
AerSale Corporation (ASLE) Misses Q3 Earnings and Revenue Estimates

AerSale Corporation (ASLE) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.04 per share a year ago. These

AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Tops Revenue Estimates
AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Tops Revenue Estimates

AbCellera Biologics Inc. (ABCL) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.17 per share a year ago. These